The kynurenine pathway and neurodegenerative disease
Neuroactive metabolites of the kynurenine pathway (KP) of tryptophan degradation have been closely linked to the pathogenesis of several neurodegenerative diseases. Tryptophan is an essential amino acid required for protein synthesis, and in higher eukaryotes is also converted into the key neurotran...
Saved in:
| Published in | Seminars in cell & developmental biology Vol. 40; pp. 134 - 141 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Ltd
01.04.2015
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1084-9521 1096-3634 1096-3634 |
| DOI | 10.1016/j.semcdb.2015.03.002 |
Cover
| Abstract | Neuroactive metabolites of the kynurenine pathway (KP) of tryptophan degradation have been closely linked to the pathogenesis of several neurodegenerative diseases. Tryptophan is an essential amino acid required for protein synthesis, and in higher eukaryotes is also converted into the key neurotransmitters serotonin and tryptamine. However, in mammals >95% of tryptophan is metabolized through the KP, ultimately leading to the production of nicotinamide adenosine dinucleotide (NAD+). A number of the pathway metabolites are neuroactive; e.g. can modulate activity of several glutamate receptors and generate/scavenge free radicals. Imbalances in absolute and relative levels of KP metabolites have been strongly associated with neurodegenerative disorders including Huntington's, Alzheimer's, and Parkinson's diseases. The KP has also been implicated in the pathogenesis of other brain disorders (e.g. schizophrenia, bipolar disorder), as well as several cancers and autoimmune disorders such as HIV. Pharmacological and genetic manipulation of the KP has been shown to ameliorate neurodegenerative phenotypes in a number of model organisms, suggesting that it could prove to be a viable target for the treatment of such diseases. Here, we provide an overview of the KP, its role in neurodegeneration and the current strategies for therapeutic targeting of the pathway. |
|---|---|
| AbstractList | Neuroactive metabolites of the kynurenine pathway (KP) of tryptophan degradation have been closely linked to the pathogenesis of several neurodegenerative diseases. Tryptophan is an essential amino acid required for protein synthesis, and in higher eukaryotes is also converted into the key neurotransmitters serotonin and tryptamine. However, in mammals >95% of tryptophan is metabolized through the KP, ultimately leading to the production of nicotinamide adenosine dinucleotide (NAD+). A number of the pathway metabolites are neuroactive; e.g. can modulate activity of several glutamate receptors and generate/scavenge free radicals. Imbalances in absolute and relative levels of KP metabolites have been strongly associated with neurodegenerative disorders including Huntington's, Alzheimer's, and Parkinson's diseases. The KP has also been implicated in the pathogenesis of other brain disorders (e.g. schizophrenia, bipolar disorder), as well as several cancers and autoimmune disorders such as HIV. Pharmacological and genetic manipulation of the KP has been shown to ameliorate neurodegenerative phenotypes in a number of model organisms, suggesting that it could prove to be a viable target for the treatment of such diseases. Here, we provide an overview of the KP, its role in neurodegeneration and the current strategies for therapeutic targeting of the pathway. Neuroactive metabolites of the kynurenine pathway (KP) of tryptophan degradation have been closely linked to the pathogenesis of several neurodegenerative diseases. Tryptophan is an essential amino acid required for protein synthesis, and in higher eukaryotes is also converted into the key neurotransmitters serotonin and tryptamine. However, in mammals >95% of tryptophan is metabolized through the KP, ultimately leading to the production of nicotinamide adenosine dinucleotide (NAD(+)). A number of the pathway metabolites are neuroactive; e.g. can modulate activity of several glutamate receptors and generate/scavenge free radicals. Imbalances in absolute and relative levels of KP metabolites have been strongly associated with neurodegenerative disorders including Huntington's, Alzheimer's, and Parkinson's diseases. The KP has also been implicated in the pathogenesis of other brain disorders (e.g. schizophrenia, bipolar disorder), as well as several cancers and autoimmune disorders such as HIV. Pharmacological and genetic manipulation of the KP has been shown to ameliorate neurodegenerative phenotypes in a number of model organisms, suggesting that it could prove to be a viable target for the treatment of such diseases. Here, we provide an overview of the KP, its role in neurodegeneration and the current strategies for therapeutic targeting of the pathway.Neuroactive metabolites of the kynurenine pathway (KP) of tryptophan degradation have been closely linked to the pathogenesis of several neurodegenerative diseases. Tryptophan is an essential amino acid required for protein synthesis, and in higher eukaryotes is also converted into the key neurotransmitters serotonin and tryptamine. However, in mammals >95% of tryptophan is metabolized through the KP, ultimately leading to the production of nicotinamide adenosine dinucleotide (NAD(+)). A number of the pathway metabolites are neuroactive; e.g. can modulate activity of several glutamate receptors and generate/scavenge free radicals. Imbalances in absolute and relative levels of KP metabolites have been strongly associated with neurodegenerative disorders including Huntington's, Alzheimer's, and Parkinson's diseases. The KP has also been implicated in the pathogenesis of other brain disorders (e.g. schizophrenia, bipolar disorder), as well as several cancers and autoimmune disorders such as HIV. Pharmacological and genetic manipulation of the KP has been shown to ameliorate neurodegenerative phenotypes in a number of model organisms, suggesting that it could prove to be a viable target for the treatment of such diseases. Here, we provide an overview of the KP, its role in neurodegeneration and the current strategies for therapeutic targeting of the pathway. |
| Author | Maddison, Daniel C. Giorgini, Flaviano |
| Author_xml | – sequence: 1 givenname: Daniel C. surname: Maddison fullname: Maddison, Daniel C. – sequence: 2 givenname: Flaviano surname: Giorgini fullname: Giorgini, Flaviano email: fg36@le.ac.uk |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25773161$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkD1PwzAQhi1URGnhHyCUkSXB304YkFDFl1SJpcyWE1-oS-sUOynqvydVCwMDTHfD8766e0Zo4BsPCF0QnBFM5PUii7CqbJlRTESGWYYxPUKnBBcyZZLxwW7PeVoISoZoFOMCY8wLKk_QkAqlGJHkFPHZHJL3re8CeOchWZt2_mm2ifE28dCFxsIbeAimdRtIrItgIpyh49osI5wf5hi9PtzPJk_p9OXxeXI3TSvBeZsqpQSRBRemrktuRMFsKbgUORBJsaJGEMZ4zmomeX9aLZWyFvOc5ByooMDG6Grfuw7NRwex1SsXK1gujYemi7ovF0WuCkV69PKAduUKrF4HtzJhq78_7QG-B6rQxBig_kEI1juheqH3QvVOqMZM90L72M2vWOXaXkbj22Dc8r_w7T4MvaSNg6Bj5cBXYF2AqtW2cX8XfAHFz5Da |
| CitedBy_id | crossref_primary_10_1016_j_heliyon_2025_e42349 crossref_primary_10_1097_FBP_0000000000000477 crossref_primary_10_1080_10826076_2019_1574815 crossref_primary_10_1007_s12035_021_02303_2 crossref_primary_10_3389_fphar_2022_1046818 crossref_primary_10_3390_biology11101416 crossref_primary_10_3390_ijms23010305 crossref_primary_10_1007_s12035_015_9548_9 crossref_primary_10_1038_s41573_019_0016_5 crossref_primary_10_1007_s12035_021_02375_0 crossref_primary_10_1016_j_drudis_2021_02_009 crossref_primary_10_1016_j_arr_2020_101165 crossref_primary_10_1007_s00109_020_01988_7 crossref_primary_10_3389_fimmu_2022_985378 crossref_primary_10_1016_j_neubiorev_2020_08_010 crossref_primary_10_7759_cureus_23690 crossref_primary_10_3389_fcimb_2022_803502 crossref_primary_10_3390_biom10070993 crossref_primary_10_3897_pharmacia_72_e148033 crossref_primary_10_1016_j_cyto_2023_156237 crossref_primary_10_1002_jnr_24980 crossref_primary_10_3390_jpm13091311 crossref_primary_10_1016_j_biopha_2017_03_082 crossref_primary_10_1681_ASN_2015070835 crossref_primary_10_3389_fnagi_2017_00193 crossref_primary_10_3389_fnut_2021_750333 crossref_primary_10_1007_s40495_019_00208_2 crossref_primary_10_3390_ijerph13050501 crossref_primary_10_3390_molecules26113423 crossref_primary_10_1002_acn3_637 crossref_primary_10_1016_j_neuroimage_2021_118842 crossref_primary_10_1002_anie_202209374 crossref_primary_10_3389_fimmu_2022_1013784 crossref_primary_10_3389_frph_2024_1453714 crossref_primary_10_1016_j_talanta_2019_120403 crossref_primary_10_3389_fphys_2019_01254 crossref_primary_10_3389_fnins_2024_1481390 crossref_primary_10_1016_j_intimp_2024_112062 crossref_primary_10_1016_j_bioorg_2024_107740 crossref_primary_10_3390_cells9081904 crossref_primary_10_1016_j_jdermsci_2024_06_003 crossref_primary_10_1161_JAHA_121_021071 crossref_primary_10_1111_dmcn_14774 crossref_primary_10_1007_s12640_017_9848_0 crossref_primary_10_1186_s12993_025_00268_z crossref_primary_10_3390_antiox10111795 crossref_primary_10_1007_s12035_017_0706_0 crossref_primary_10_1016_j_biopha_2024_117802 crossref_primary_10_1080_08830185_2021_1954638 crossref_primary_10_3389_fcimb_2022_815738 crossref_primary_10_3390_antiox9050437 crossref_primary_10_1016_j_mad_2021_111567 crossref_primary_10_3390_neuroglia6010014 crossref_primary_10_1016_j_bbr_2017_04_020 crossref_primary_10_1016_j_ejmech_2023_115258 crossref_primary_10_1021_acs_analchem_8b04852 crossref_primary_10_1016_j_msard_2023_104898 crossref_primary_10_1186_s12943_024_02164_y crossref_primary_10_3389_fneur_2022_1029891 crossref_primary_10_1016_j_bbi_2016_03_002 crossref_primary_10_1186_s13229_016_0109_5 crossref_primary_10_1159_000515066 crossref_primary_10_3390_ijms21186546 crossref_primary_10_18231_j_ijcaap_2023_026 crossref_primary_10_3389_fnmol_2023_1305208 crossref_primary_10_1038_s41582_021_00592_8 crossref_primary_10_1016_j_jpsychires_2024_09_008 crossref_primary_10_1007_s11255_023_03691_1 crossref_primary_10_1016_j_semcdb_2015_04_006 crossref_primary_10_1038_s41537_025_00559_4 crossref_primary_10_18632_aging_205220 crossref_primary_10_1007_s11655_022_3570_3 crossref_primary_10_1021_acschemneuro_9b00265 crossref_primary_10_1016_j_pep_2016_01_004 crossref_primary_10_1007_s00737_018_0898_y crossref_primary_10_3389_fonc_2019_00663 crossref_primary_10_1371_journal_pgen_1009129 crossref_primary_10_1007_s11033_021_06935_4 crossref_primary_10_2174_1871527321666220701152821 crossref_primary_10_1007_s11064_022_03546_8 crossref_primary_10_1016_j_jmsacl_2023_04_003 crossref_primary_10_3389_fphar_2021_687757 crossref_primary_10_1186_s13195_024_01623_4 crossref_primary_10_1186_s40478_018_0640_z crossref_primary_10_1038_s41598_021_84858_7 crossref_primary_10_1096_fj_201700397RR crossref_primary_10_1007_s11011_017_0178_y crossref_primary_10_1016_j_chroma_2020_461775 crossref_primary_10_1016_j_ejphar_2015_06_036 crossref_primary_10_3389_fpsyt_2022_996406 crossref_primary_10_1016_j_pnpbp_2017_03_016 crossref_primary_10_3390_ijms252312767 crossref_primary_10_1016_j_bbi_2017_11_017 crossref_primary_10_1038_s41593_018_0253_7 crossref_primary_10_2174_0118715273282363240415045927 crossref_primary_10_1016_j_ejphar_2024_176420 crossref_primary_10_1038_s41598_022_10075_5 crossref_primary_10_1016_j_neuropharm_2015_12_004 crossref_primary_10_3390_ijms24066010 crossref_primary_10_3389_fnmol_2023_1237745 crossref_primary_10_1111_jnc_15360 crossref_primary_10_2141_jpsa_2023004 crossref_primary_10_3389_fmed_2018_00061 crossref_primary_10_1070_RCR4954 crossref_primary_10_18632_aging_202501 crossref_primary_10_1016_j_mcn_2018_01_005 crossref_primary_10_1111_jdv_14460 crossref_primary_10_1007_s11481_016_9668_7 crossref_primary_10_3390_ijms22136737 crossref_primary_10_1016_j_foodchem_2020_128415 crossref_primary_10_3389_fphys_2019_01081 crossref_primary_10_3390_ijms24065742 crossref_primary_10_1111_jnc_14843 crossref_primary_10_1007_s11064_020_03002_5 crossref_primary_10_1016_j_expneurol_2016_05_005 crossref_primary_10_1007_s40473_018_0147_8 crossref_primary_10_1111_jnc_13874 crossref_primary_10_1002_fsn3_1418 crossref_primary_10_1177_1178646918776658 crossref_primary_10_1016_j_aqrep_2024_102392 crossref_primary_10_1038_s42003_021_01666_5 crossref_primary_10_1371_journal_pntd_0005140 crossref_primary_10_1016_j_chroma_2020_461128 crossref_primary_10_1177_1178646921991119 crossref_primary_10_1007_s12325_022_02241_y crossref_primary_10_1111_febs_16086 crossref_primary_10_1007_s12035_017_0845_3 crossref_primary_10_3389_fphar_2019_01044 crossref_primary_10_1016_j_bbr_2018_01_024 crossref_primary_10_1177_11786469231211184 crossref_primary_10_1126_science_abm6131 crossref_primary_10_1016_j_virol_2016_01_023 crossref_primary_10_3389_fimmu_2021_701550 crossref_primary_10_1021_acs_jmedchem_1c00303 crossref_primary_10_1080_14756366_2020_1755670 crossref_primary_10_1038_srep39199 crossref_primary_10_1007_s00018_017_2674_y crossref_primary_10_1016_j_bmcl_2020_127753 crossref_primary_10_1016_j_pharmthera_2020_107746 crossref_primary_10_1002_ange_202209374 crossref_primary_10_1038_s42003_019_0520_5 crossref_primary_10_14336_AD_2022_0916 crossref_primary_10_1073_pnas_1604453113 crossref_primary_10_1016_j_mam_2016_08_001 crossref_primary_10_1016_j_jchromb_2021_122846 crossref_primary_10_1016_j_mcna_2022_09_001 crossref_primary_10_1016_j_molliq_2024_124756 crossref_primary_10_1002_brb3_1566 crossref_primary_10_3233_JAD_170447 crossref_primary_10_1016_j_foodres_2019_108744 crossref_primary_10_3390_ijms24032737 crossref_primary_10_1016_j_ymben_2018_11_010 crossref_primary_10_3390_ijerph182111545 crossref_primary_10_1111_jnc_16015 crossref_primary_10_1159_000526647 crossref_primary_10_1186_s12974_024_03296_0 crossref_primary_10_1007_s12264_023_01072_3 crossref_primary_10_1186_s13578_021_00705_2 crossref_primary_10_1016_j_ebiom_2022_104280 crossref_primary_10_1016_j_neubiorev_2021_01_011 crossref_primary_10_1039_D3CB00052D crossref_primary_10_1016_j_jneuroim_2023_578155 crossref_primary_10_1111_cbdd_13197 crossref_primary_10_1186_s40104_023_00903_7 crossref_primary_10_3390_ph16040615 crossref_primary_10_1007_s00429_016_1299_5 crossref_primary_10_1007_s12035_023_03815_9 crossref_primary_10_3389_fimmu_2022_1088124 crossref_primary_10_3389_fnins_2019_00220 crossref_primary_10_1016_j_isci_2024_109628 crossref_primary_10_1016_j_taap_2024_117161 crossref_primary_10_1016_j_cca_2019_10_023 crossref_primary_10_1177_1178646920972657 crossref_primary_10_1016_j_bbr_2017_05_024 crossref_primary_10_1016_j_gpb_2016_12_007 crossref_primary_10_1016_j_pharmthera_2021_107845 crossref_primary_10_1371_journal_pgen_1010644 crossref_primary_10_1016_j_neuroscience_2017_03_011 crossref_primary_10_1136_jim_2018_000742 crossref_primary_10_1210_jc_2018_02481 crossref_primary_10_1016_j_cmet_2019_09_001 crossref_primary_10_1155_2022_8584558 crossref_primary_10_3390_ijms242216304 crossref_primary_10_1016_j_bmcl_2021_128115 crossref_primary_10_1016_j_brainresbull_2021_04_010 crossref_primary_10_1016_j_neuroscience_2019_01_014 crossref_primary_10_3390_foods14071103 crossref_primary_10_1038_s41467_022_34068_0 crossref_primary_10_3390_biomedicines10092294 crossref_primary_10_3390_cells12071087 crossref_primary_10_1038_s41380_019_0414_4 crossref_primary_10_3390_brainsci10090631 crossref_primary_10_3892_mmr_2019_10225 crossref_primary_10_1096_fj_202001880R crossref_primary_10_3389_fimmu_2021_702048 crossref_primary_10_3390_biom10040571 crossref_primary_10_1007_s41975_021_00184_1 crossref_primary_10_3390_molecules26113314 crossref_primary_10_1016_j_psyneuen_2021_105287 crossref_primary_10_2141_jpsa_2025013 crossref_primary_10_1002_ptr_5850 crossref_primary_10_2174_1570159X21666230703091435 crossref_primary_10_1016_j_chemosphere_2020_126715 crossref_primary_10_1016_j_exger_2019_110793 crossref_primary_10_1007_s10048_024_00792_6 crossref_primary_10_1186_s12883_019_1267_9 crossref_primary_10_3389_fphar_2021_667874 crossref_primary_10_3233_JAD_170485 crossref_primary_10_1016_j_neures_2021_08_003 crossref_primary_10_2174_1568026622666220718155616 crossref_primary_10_1038_s41581_018_0018_2 crossref_primary_10_1194_jlr_M079251 crossref_primary_10_1007_s12035_017_0761_6 crossref_primary_10_1111_ejn_15188 crossref_primary_10_1038_s41598_018_37657_6 crossref_primary_10_1016_j_freeradbiomed_2017_10_379 crossref_primary_10_3390_ijms21103575 crossref_primary_10_1007_s00415_023_11572_x crossref_primary_10_1016_j_exger_2021_111452 |
| Cites_doi | 10.1002/mds.20596 10.1080/10715760100300391 10.1111/j.1471-4159.2005.03070.x 10.1016/0022-510X(94)00280-2 10.1016/j.cub.2011.04.028 10.1097/00001756-200312190-00005 10.1007/BF00964611 10.1038/nature12039 10.1016/S0006-291X(02)02917-0 10.1124/dmd.112.046532 10.1016/S0197-0186(97)90002-4 10.1016/0304-3940(89)90609-5 10.1021/jm970467t 10.1046/j.1471-4159.1998.70010299.x 10.1073/pnas.93.22.12553 10.3389/fnins.2014.00012 10.1111/j.1471-4159.2009.06442.x 10.1023/A:1020700401678 10.1042/bj2510893 10.1093/brain/awm044 10.1016/0006-8993(82)91048-4 10.1016/S0021-9258(19)77982-4 10.1007/s12640-009-9051-z 10.1016/j.euroneuro.2013.03.008 10.1080/10715760000300021 10.1007/BF01262727 10.1016/S0197-0186(01)00133-4 10.1074/jbc.M708192200 10.1016/0006-8993(85)90647-X 10.1007/BF00966592 10.1021/bi992997s 10.1002/arch.20159 10.1038/npp.2011.277 10.1016/j.neulet.2008.06.007 10.1007/s00406-012-0384-x 10.1021/jm501350y 10.1016/j.cell.2011.05.020 10.1111/j.1471-4159.1993.tb05840.x 10.1111/j.1471-4159.1991.tb03460.x 10.1212/WNL.42.9.1702 10.1016/0306-4522(96)00034-6 10.1016/S0006-8993(98)00577-0 10.1111/j.1471-4159.1986.tb02826.x 10.1016/j.nbd.2006.02.011 10.1046/j.1471-4159.1997.69010290.x 10.1093/hmg/ddp527 10.1006/abbi.2000.1755 10.1016/j.ntt.2011.07.002 10.1073/pnas.1203083109 10.3233/JAD-2010-100684 10.1046/j.1460-9568.1999.00806.x 10.1111/j.1471-4159.1990.tb13296.x 10.1046/j.1471-4159.2001.00498.x 10.1093/brain/116.6.1425 10.1038/ng1542 10.1111/j.1742-4658.2007.05635.x 10.1016/0014-2999(81)90587-2 10.1084/jem.20080178 10.1042/BST0370408 10.1016/j.nbd.2004.07.006 10.1016/0028-3908(83)90221-6 10.1523/JNEUROSCI.21-19-07463.2001 10.1074/jbc.M113.503813 10.1073/pnas.87.7.2506 10.3233/JAD-140414 10.1002/prot.24653 10.1016/j.expneurol.2013.08.007 10.1007/s12640-009-9034-0 10.1038/sj.bjp.0702940 10.1111/j.1365-2990.2005.00655.x 10.1007/s007020200014 10.1093/brain/115.5.1249 10.1007/978-1-4615-0135-0_12 10.1016/S1474-4422(10)70245-3 10.1007/s00109-013-1046-9 10.1073/pnas.0308679101 10.2478/v10039-010-0023-6 10.1038/npp.2013.71 10.1126/science.6849138 10.1016/j.ics.2007.07.026 10.1016/j.brainres.2014.09.034 10.1371/journal.pone.0006344 10.1111/j.1471-4159.2010.06675.x 10.1179/174329210X12650506623645 10.1097/WNR.0b013e32832e34ee 10.1002/glia.1072 10.1016/j.neuint.2006.04.017 10.1074/jbc.271.32.19140 10.1002/mds.26007 10.1016/0304-3940(93)90796-N 10.1016/S0891-5849(99)00272-5 10.1111/j.1471-4159.2009.06175.x |
| ContentType | Journal Article |
| Copyright | 2015 Elsevier Ltd Copyright © 2015 Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2015 Elsevier Ltd – notice: Copyright © 2015 Elsevier Ltd. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.semcdb.2015.03.002 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1096-3634 |
| EndPage | 141 |
| ExternalDocumentID | 25773161 10_1016_j_semcdb_2015_03_002 S1084952115000452 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Biotechnology and Biological Sciences Research Council – fundername: Medical Research Council grantid: MC_PC_14117 |
| GroupedDBID | --- --K --M -DZ .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABFRF ABGSF ABJNI ABLJU ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CAG COF CS3 DM4 DOVZS DU5 EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HX~ HZ~ IHE J1W KOM LG5 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UDS XPP ZMT ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO ADVLN AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH CGR CUY CVF ECM EFKBS EIF NPM 7X8 ACLOT ~HD |
| ID | FETCH-LOGICAL-c544t-777516945affb4a593db54658e162072a5133483f364004f677dd048184e252e3 |
| IEDL.DBID | .~1 |
| ISSN | 1084-9521 1096-3634 |
| IngestDate | Sun Sep 28 04:56:49 EDT 2025 Mon Jul 21 05:57:09 EDT 2025 Tue Jul 01 04:33:08 EDT 2025 Thu Apr 24 23:11:46 EDT 2025 Fri Feb 23 02:25:14 EST 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | KYNA TNFα BBB Parkinson's disease QPRT CNS HTT mHTT 3-HK aSyn INF-γ LPS Aβ IDO Neurodegeneration ACMS KYNU CSF NMDA Kynurenine 3-monooxygenase iNOS Alzheimer's disease TDO Kynurenine pathway AD IL 3-HANA KP FAD GST SOD IL-1β KMO Huntington's disease QUIN NAD α7nACh PD l-TRP nNOS ROS 3-HAO GAS l-KYN HD OGT HDAC KAT |
| Language | English |
| License | Copyright © 2015 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c544t-777516945affb4a593db54658e162072a5133483f364004f677dd048184e252e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | http://www.sciencedirect.com/science/article/pii/S1084952115000452 |
| PMID | 25773161 |
| PQID | 1695987971 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_1695987971 pubmed_primary_25773161 crossref_primary_10_1016_j_semcdb_2015_03_002 crossref_citationtrail_10_1016_j_semcdb_2015_03_002 elsevier_sciencedirect_doi_10_1016_j_semcdb_2015_03_002 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-04-01 |
| PublicationDateYYYYMMDD | 2015-04-01 |
| PublicationDate_xml | – month: 04 year: 2015 text: 2015-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Seminars in cell & developmental biology |
| PublicationTitleAlternate | Semin Cell Dev Biol |
| PublicationYear | 2015 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Forrest, Mackay, Stoy, Spiden, Taylor, Stone (bib0785) 2010; 112 Ogawa, Matson, Beal, Myers, Bird, Milbury (bib0860) 1992; 42 Schwarcz, Whetsell, Mangano (bib0490) 1983; 219 Li, Han, Fang, Rizzi, James, Li (bib0645) 2007; 64 Sathyasaikumar, Stachowski, Amori, Guidetti, Muchowski, Schwarcz (bib0790) 2010; 113 Foster, Whetsell, Bird, Schwarcz (bib0470) 1985; 336 Leipnitz, Schumacher, Dalcin, Scussiato, Solano, Funchal (bib0605) 2007; 50 Pucci, Perozzi, Cimadamore, Orsomando, Raffaelli (bib0475) 2007; 274 Guillemin, Smythe, Veas, Takikawa, Brew (bib0830) 2003; 14 Vazquez, Garner, Sheil, Truscott (bib0560) 2000; 32 Gulaj, Pawlak, Bien, Pawlak (bib0810) 2010; 55 Walker, Budac, Bisulco, Lee, Smith, Beenders (bib0650) 2013; 38 Silvestroni, Faull, Strand, Moller (bib0800) 2009; 20 Zunszain, Anacker, Cattaneo, Choudhury, Musaelyan, Myint (bib0670) 2012; 37 Amaral, Levy, Heyes, Lafite, Outeiro, Giorgini (bib0915) 2013; 496 Rios, Santamaria (bib0520) 1991; 16 Amaral, Outeiro, Scrutton, Giorgini (bib0880) 2013; 91 Iwahashi, Ishii, Sugata, Kido (bib0595) 1988; 251 Perkins, Stone (bib0625) 1982; 247 Guillemin, Smith, Smythe, Armati, Brew (bib0690) 2003; 527 Speciale, Schwarcz (bib0725) 1993; 60 Santamaria, Rios (bib0525) 1993; 159 Goldstein, Leopold, Huang, Atwood, Saunders, Hartshorn (bib0590) 2000; 39 Widner, Leblhuber, Fuchs (bib0855) 2002; 109 Campesan, Green, Breda, Sathyasaikumar, Muchowski, Schwarcz (bib0870) 2011; 21 Yu, Tao, Yang, Du, Yang, He (bib0930) 2015; 43 Zwilling, Huang, Sathyasaikumar, Notarangelo, Guidetti, Wu (bib0875) 2011; 145 Lapin (bib0485) 1978; 42 Samadi, Gregoire, Rassoulpour, Guidetti, Izzo, Schwarcz (bib0890) 2005; 20 Guillemin, Brew, Noonan, Takikawa, Cullen (bib0825) 2005; 31 Mazarei, Budac, Lu, Lee, Moller, Leavitt (bib1930) 2013; 249 Stipek, Stastny, Platenik, Crkovska, Zima (bib0530) 1997; 30 Platenik, Stopka, Vejrazka, Stipek (bib0535) 2001; 34 Mazarei, Neal, Becanovic, Luthi-Carter, Simpson, Leavitt (bib0775) 2010; 19 Dang, Dale, Brown (bib0695) 2000; 28 Smith, Smith, Stone (bib0580) 2009; 15 Beconi, Yates, Lyons, Matthews, Clifton, Mead (bib0895) 2012; 40 Ren, Correia (bib0640) 2000; 377 Guidetti, Luthi-Carter, Augood, Schwarcz (bib0755) 2004; 17 Nakao, Grasbon-Frodl, Widner, Brundin (bib0555) 1996; 73 Giorgini, Huang, Sathyasaikumar, Notarangelo, Thomas, Tararina (bib0910) 2013; 288 Giles, Collins, Stone, Jacob (bib0565) 2003; 300 Wild, Tabrizi (bib0900) 2014; 29 Behan, McDonald, Darlington, Stone (bib0550) 1999; 128 Konan, Taylor (bib0655) 1996; 271 Rahman, Ting, Cullen, Braidy, Brew, Guillemin (bib0850) 2009; 4 Jauch, Urbanska, Guidetti, Bird, Vonsattel, Whetsell (bib0760) 1995; 130 Foster, Collins, Schwarcz (bib0495) 1983; 22 Hilmas, Pereira, Alkondon, Rassoulpour, Schwarcz, Albuquerque (bib0620) 2001; 21 Okuda, Nishiyama, Saito, Katsuki (bib0575) 1998; 70 Bjorkqvist, Wild, Thiele, Silvestroni, Andre, Lahiri (bib0795) 2008; 205 Schwarz, Guillemin, Teipel, Buerger, Hampel (bib0820) 2013; 263 Rassoulpour, Wu, Poeggeler, Schwarcz (bib0720) 1998; 802 Heyes, Saito, Major, Milstien, Markey, Vickers (bib0730) 1993; 116 Tai, Pavese, Gerhard, Tabrizi, Barker, Brooks (bib0805) 2007; 130 Yu, Zheng, Kuang, Huang, Yang (bib0925) 2010; 22 Meng, Wu, Gu, Ouyang, Ding, Liu (bib0635) 2014; 82 Campbell, Charych, Lee, Moller (bib0660) 2014; 8 Perez-Severiano, Escalante, Rios (bib0545) 1998; 23 Guillemin, Kerr, Smythe, Smith, Kapoor, Armati (bib0710) 2001; 78 Braidy, Grant, Adams, Brew, Guillemin (bib0540) 2009; 16 Wexler, Lorimer, Porter, Gomez, Moskowitz, Shackell (bib0750) 2004; 101 Ting, Brew, Guillemin (bib0510) 2009; 6 Giorgini, Guidetti, Nguyen, Bennett, Muchowski (bib0865) 2005; 37 Gal, Sherman (bib0700) 1980; 5 Lugo-Huitron, Blanco-Ayala, Ugalde-Muniz, Carrillo-Mora, Pedraza-Chaverri, Silva-Adaya (bib0615) 2011; 33 Giorgini, Moller, Kwan, Zwilling, Wacker, Hong (bib0685) 2008; 283 Ross, Tabrizi (bib0745) 2011; 10 Okuda, Nishiyama, Saito, Katsuki (bib0570) 1996; 93 Connor, Starr, O'Sullivan, Harkin (bib0675) 2008; 441 Fukui, Schwarcz, Rapoport, Takada, Smith (bib0740) 1991; 56 Lue, Rydel, Brigham, Yang, Hampel, Murphy (bib0840) 2001; 35 Rafice, Chauhan, Efimov, Basran, Raven (bib0630) 2009; 37 Rover, Cesura, Huguenin, Kettler, Szente (bib0885) 1997; 40 Guidetti, Schwarcz (bib0585) 1999; 11 Yamada, Akimoto, Kagawa, Guillemin, Takikawa (bib0835) 2009; 110 Takikawa, Kuroiwa, Yamazaki, Kido (bib0665) 1988; 263 Foster, White, Schwarcz (bib0735) 1986; 47 Akimoto, Yamada, Takikawa (bib0845) 2007; 1304 Guidetti, Bates, Graham, Hayden, Leavitt, MacDonald (bib0770) 2006; 23 Bonda, Mailankot, Stone, Garrett, Staniszewska, Castellani (bib0815) 2010; 15 Christen, Peterhans, Stocker (bib0600) 1990; 87 Colin-Gonzalez, Maya-Lopez, Pedraza-Chaverri, Ali, Chavarria, Santamaria (bib0610) 2014; 1589 Speciale, Schwarcz (bib0705) 1990; 54 Gramsbergen, Hodgkins, Rassoulpour, Turski, Guidetti, Schwarcz (bib0715) 1997; 69 Whetsell, Schwarcz (bib0500) 1989; 97 Perez-De La Cruz, Carrillo-Mora, Santamaria (bib0515) 2012; 5 van der Goot, Zhu, Vazquez-Manrique, Seinstra, Dettmer, Michels (bib0920) 2012; 109 Toledo-Sherman, Prime, Mrzljak, Beconi, Beresford, Brookfield (bib0905) 2015; 58 Molteni, Macchi, Zecchillo, Dell’agli, Colombo, Calabrese (bib0680) 2013; 23 Tavares, Tasca, Santos, Alves, Porciuncula, Emanuelli (bib0505) 2002; 40 Stoy, Mackay, Forrest, Christofides, Egerton, Stone (bib0780) 2005; 93 Stone, Perkins (bib0480) 1981; 72 Heyes, Saito, Crowley, Davis, Demitrack, Der (bib0765) 1992; 115 Lugo-Huitron (10.1016/j.semcdb.2015.03.002_bib0615) 2011; 33 Christen (10.1016/j.semcdb.2015.03.002_bib0600) 1990; 87 Silvestroni (10.1016/j.semcdb.2015.03.002_bib0800) 2009; 20 Okuda (10.1016/j.semcdb.2015.03.002_bib0575) 1998; 70 Rassoulpour (10.1016/j.semcdb.2015.03.002_bib0720) 1998; 802 Schwarz (10.1016/j.semcdb.2015.03.002_bib0820) 2013; 263 Giles (10.1016/j.semcdb.2015.03.002_bib0565) 2003; 300 Yu (10.1016/j.semcdb.2015.03.002_bib0930) 2015; 43 Widner (10.1016/j.semcdb.2015.03.002_bib0855) 2002; 109 Rahman (10.1016/j.semcdb.2015.03.002_bib0850) 2009; 4 Okuda (10.1016/j.semcdb.2015.03.002_bib0570) 1996; 93 Vazquez (10.1016/j.semcdb.2015.03.002_bib0560) 2000; 32 Perez-Severiano (10.1016/j.semcdb.2015.03.002_bib0545) 1998; 23 Whetsell (10.1016/j.semcdb.2015.03.002_bib0500) 1989; 97 Beconi (10.1016/j.semcdb.2015.03.002_bib0895) 2012; 40 Tai (10.1016/j.semcdb.2015.03.002_bib0805) 2007; 130 Braidy (10.1016/j.semcdb.2015.03.002_bib0540) 2009; 16 Giorgini (10.1016/j.semcdb.2015.03.002_bib0910) 2013; 288 Campesan (10.1016/j.semcdb.2015.03.002_bib0870) 2011; 21 Toledo-Sherman (10.1016/j.semcdb.2015.03.002_bib0905) 2015; 58 Hilmas (10.1016/j.semcdb.2015.03.002_bib0620) 2001; 21 Giorgini (10.1016/j.semcdb.2015.03.002_bib0685) 2008; 283 Guidetti (10.1016/j.semcdb.2015.03.002_bib0770) 2006; 23 Stipek (10.1016/j.semcdb.2015.03.002_bib0530) 1997; 30 Leipnitz (10.1016/j.semcdb.2015.03.002_bib0605) 2007; 50 Foster (10.1016/j.semcdb.2015.03.002_bib0470) 1985; 336 Rafice (10.1016/j.semcdb.2015.03.002_bib0630) 2009; 37 Molteni (10.1016/j.semcdb.2015.03.002_bib0680) 2013; 23 Speciale (10.1016/j.semcdb.2015.03.002_bib0725) 1993; 60 Platenik (10.1016/j.semcdb.2015.03.002_bib0535) 2001; 34 Stone (10.1016/j.semcdb.2015.03.002_bib0480) 1981; 72 Sathyasaikumar (10.1016/j.semcdb.2015.03.002_bib0790) 2010; 113 Zunszain (10.1016/j.semcdb.2015.03.002_bib0670) 2012; 37 Ting (10.1016/j.semcdb.2015.03.002_bib0510) 2009; 6 Wexler (10.1016/j.semcdb.2015.03.002_bib0750) 2004; 101 Mazarei (10.1016/j.semcdb.2015.03.002_bib0775) 2010; 19 Amaral (10.1016/j.semcdb.2015.03.002_bib0915) 2013; 496 Meng (10.1016/j.semcdb.2015.03.002_bib0635) 2014; 82 Heyes (10.1016/j.semcdb.2015.03.002_bib0765) 1992; 115 Guillemin (10.1016/j.semcdb.2015.03.002_bib0690) 2003; 527 Heyes (10.1016/j.semcdb.2015.03.002_bib0730) 1993; 116 Ren (10.1016/j.semcdb.2015.03.002_bib0640) 2000; 377 Guidetti (10.1016/j.semcdb.2015.03.002_bib0755) 2004; 17 Rios (10.1016/j.semcdb.2015.03.002_bib0520) 1991; 16 Yu (10.1016/j.semcdb.2015.03.002_bib0925) 2010; 22 Forrest (10.1016/j.semcdb.2015.03.002_bib0785) 2010; 112 Smith (10.1016/j.semcdb.2015.03.002_bib0580) 2009; 15 Behan (10.1016/j.semcdb.2015.03.002_bib0550) 1999; 128 Guidetti (10.1016/j.semcdb.2015.03.002_bib0585) 1999; 11 Fukui (10.1016/j.semcdb.2015.03.002_bib0740) 1991; 56 Zwilling (10.1016/j.semcdb.2015.03.002_bib0875) 2011; 145 Takikawa (10.1016/j.semcdb.2015.03.002_bib0665) 1988; 263 Dang (10.1016/j.semcdb.2015.03.002_bib0695) 2000; 28 Ross (10.1016/j.semcdb.2015.03.002_bib0745) 2011; 10 Lapin (10.1016/j.semcdb.2015.03.002_bib0485) 1978; 42 Foster (10.1016/j.semcdb.2015.03.002_bib0735) 1986; 47 Goldstein (10.1016/j.semcdb.2015.03.002_bib0590) 2000; 39 Pucci (10.1016/j.semcdb.2015.03.002_bib0475) 2007; 274 Gulaj (10.1016/j.semcdb.2015.03.002_bib0810) 2010; 55 Giorgini (10.1016/j.semcdb.2015.03.002_bib0865) 2005; 37 Li (10.1016/j.semcdb.2015.03.002_bib0645) 2007; 64 Gramsbergen (10.1016/j.semcdb.2015.03.002_bib0715) 1997; 69 Perez-De La Cruz (10.1016/j.semcdb.2015.03.002_bib0515) 2012; 5 Lue (10.1016/j.semcdb.2015.03.002_bib0840) 2001; 35 Campbell (10.1016/j.semcdb.2015.03.002_bib0660) 2014; 8 Foster (10.1016/j.semcdb.2015.03.002_bib0495) 1983; 22 Mazarei (10.1016/j.semcdb.2015.03.002_bib1930) 2013; 249 Gal (10.1016/j.semcdb.2015.03.002_bib0700) 1980; 5 van der Goot (10.1016/j.semcdb.2015.03.002_bib0920) 2012; 109 Samadi (10.1016/j.semcdb.2015.03.002_bib0890) 2005; 20 Nakao (10.1016/j.semcdb.2015.03.002_bib0555) 1996; 73 Ogawa (10.1016/j.semcdb.2015.03.002_bib0860) 1992; 42 Jauch (10.1016/j.semcdb.2015.03.002_bib0760) 1995; 130 Rover (10.1016/j.semcdb.2015.03.002_bib0885) 1997; 40 Konan (10.1016/j.semcdb.2015.03.002_bib0655) 1996; 271 Wild (10.1016/j.semcdb.2015.03.002_bib0900) 2014; 29 Connor (10.1016/j.semcdb.2015.03.002_bib0675) 2008; 441 Schwarcz (10.1016/j.semcdb.2015.03.002_bib0490) 1983; 219 Iwahashi (10.1016/j.semcdb.2015.03.002_bib0595) 1988; 251 Bjorkqvist (10.1016/j.semcdb.2015.03.002_bib0795) 2008; 205 Santamaria (10.1016/j.semcdb.2015.03.002_bib0525) 1993; 159 Stoy (10.1016/j.semcdb.2015.03.002_bib0780) 2005; 93 Guillemin (10.1016/j.semcdb.2015.03.002_bib0825) 2005; 31 Speciale (10.1016/j.semcdb.2015.03.002_bib0705) 1990; 54 Guillemin (10.1016/j.semcdb.2015.03.002_bib0830) 2003; 14 Walker (10.1016/j.semcdb.2015.03.002_bib0650) 2013; 38 Guillemin (10.1016/j.semcdb.2015.03.002_bib0710) 2001; 78 Colin-Gonzalez (10.1016/j.semcdb.2015.03.002_bib0610) 2014; 1589 Yamada (10.1016/j.semcdb.2015.03.002_bib0835) 2009; 110 Amaral (10.1016/j.semcdb.2015.03.002_bib0880) 2013; 91 Bonda (10.1016/j.semcdb.2015.03.002_bib0815) 2010; 15 Perkins (10.1016/j.semcdb.2015.03.002_bib0625) 1982; 247 Akimoto (10.1016/j.semcdb.2015.03.002_bib0845) 2007; 1304 Tavares (10.1016/j.semcdb.2015.03.002_bib0505) 2002; 40 |
| References_xml | – volume: 43 start-page: 291 year: 2015 end-page: 302 ident: bib0930 article-title: The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer's disease publication-title: J Alzheimers Dis – volume: 1589 start-page: 1 year: 2014 end-page: 14 ident: bib0610 article-title: The Janus faces of 3-hydroxykynurenine: dual redox modulatory activity and lack of neurotoxicity in the rat striatum publication-title: Brain Res – volume: 14 start-page: 2311 year: 2003 end-page: 2315 ident: bib0830 article-title: A beta 1–42 induces production of quinolinic acid by human macrophages and microglia publication-title: Neuroreport – volume: 33 start-page: 538 year: 2011 end-page: 547 ident: bib0615 article-title: On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress publication-title: Neurotoxicol Teratol – volume: 110 start-page: 791 year: 2009 end-page: 800 ident: bib0835 article-title: Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1–42: implications for the pathogenesis of Alzheimer's disease publication-title: J Neurochem – volume: 271 start-page: 19140 year: 1996 end-page: 19145 ident: bib0655 article-title: Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene publication-title: J Biol Chem – volume: 30 start-page: 233 year: 1997 end-page: 237 ident: bib0530 article-title: The effect of quinolinate on rat brain lipid peroxidation is dependent on iron publication-title: Neurochem Int – volume: 34 start-page: 445 year: 2001 end-page: 459 ident: bib0535 article-title: Quinolinic acid–iron(ii) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction publication-title: Free Radic Res – volume: 15 start-page: 303 year: 2009 end-page: 310 ident: bib0580 article-title: 5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurones publication-title: Neurotox Res – volume: 82 start-page: 3210 year: 2014 end-page: 3216 ident: bib0635 article-title: Structural and functional analyses of human tryptophan 2,3-dioxygenase publication-title: Proteins – volume: 112 start-page: 112 year: 2010 end-page: 122 ident: bib0785 article-title: Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease publication-title: J Neurochem – volume: 37 start-page: 526 year: 2005 end-page: 531 ident: bib0865 article-title: A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease publication-title: Nat Genet – volume: 249 start-page: 144 year: 2013 end-page: 148 ident: bib1930 article-title: The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain publication-title: Exp Neurol – volume: 22 start-page: 1331 year: 1983 end-page: 1342 ident: bib0495 article-title: On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds publication-title: Neuropharmacology – volume: 39 start-page: 7266 year: 2000 end-page: 7275 ident: bib0590 article-title: 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction publication-title: Biochemistry – volume: 40 start-page: 621 year: 2002 end-page: 627 ident: bib0505 article-title: Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes publication-title: Neurochem Int – volume: 54 start-page: 156 year: 1990 end-page: 163 ident: bib0705 article-title: Uptake of kynurenine into rat brain slices publication-title: J Neurochem – volume: 4 start-page: e6344 year: 2009 ident: bib0850 article-title: The excitotoxin quinolinic acid induces tau phosphorylation in human neurons publication-title: PLoS ONE – volume: 70 start-page: 299 year: 1998 end-page: 307 ident: bib0575 article-title: 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity publication-title: J Neurochem – volume: 50 start-page: 83 year: 2007 end-page: 94 ident: bib0605 article-title: In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain publication-title: Neurochem Int – volume: 38 start-page: 1609 year: 2013 end-page: 1616 ident: bib0650 article-title: NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice publication-title: Neuropsychopharmacology – volume: 56 start-page: 2007 year: 1991 end-page: 2017 ident: bib0740 article-title: Blood–brain barrier transport of kynurenines: implications for brain synthesis and metabolism publication-title: J Neurochem – volume: 16 start-page: 1139 year: 1991 end-page: 1143 ident: bib0520 article-title: Quinolinic acid is a potent lipid peroxidant in rat brain homogenates publication-title: Neurochem Res – volume: 16 start-page: 77 year: 2009 end-page: 86 ident: bib0540 article-title: Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons publication-title: Neurotox Res – volume: 87 start-page: 2506 year: 1990 end-page: 2510 ident: bib0600 article-title: Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases publication-title: Proc Natl Acad Sci U S A – volume: 32 start-page: 11 year: 2000 end-page: 23 ident: bib0560 article-title: Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions publication-title: Free Radic Res – volume: 283 start-page: 7390 year: 2008 end-page: 7400 ident: bib0685 article-title: Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment publication-title: J Biol Chem – volume: 55 start-page: 204 year: 2010 end-page: 211 ident: bib0810 article-title: Kynurenine and its metabolites in Alzheimer's disease patients publication-title: Adv Med Sci – volume: 300 start-page: 719 year: 2003 end-page: 724 ident: bib0565 article-title: Electrochemical and in vitro evaluation of the redox-properties of kynurenine species publication-title: Biochem Biophys Res Commun – volume: 8 start-page: 12 year: 2014 ident: bib0660 article-title: Kynurenines in CNS disease: regulation by inflammatory cytokines publication-title: Front Neurosci – volume: 219 start-page: 316 year: 1983 end-page: 318 ident: bib0490 article-title: Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain publication-title: Science – volume: 64 start-page: 74 year: 2007 end-page: 87 ident: bib0645 article-title: Biochemical mechanisms leading to tryptophan 2,3-dioxygenase activation publication-title: Arch Insect Biochem Physiol – volume: 37 start-page: 408 year: 2009 end-page: 412 ident: bib0630 article-title: Oxidation of publication-title: Biochem Soc Trans – volume: 20 start-page: 792 year: 2005 end-page: 802 ident: bib0890 article-title: Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys publication-title: Mov Disord – volume: 21 start-page: 961 year: 2011 end-page: 966 ident: bib0870 article-title: The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease publication-title: Curr Biol – volume: 263 start-page: 345 year: 2013 end-page: 352 ident: bib0820 article-title: Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls publication-title: Eur Arch Psychiatry Clin Neurosci – volume: 28 start-page: 615 year: 2000 end-page: 624 ident: bib0695 article-title: Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway publication-title: Free Radic Biol Med – volume: 23 start-page: 190 year: 2006 end-page: 197 ident: bib0770 article-title: Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice publication-title: Neurobiol Dis – volume: 91 start-page: 705 year: 2013 end-page: 713 ident: bib0880 article-title: The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease publication-title: J Mol Med (Berl.) – volume: 15 start-page: 161 year: 2010 end-page: 168 ident: bib0815 article-title: Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease publication-title: Redox Rep – volume: 6 year: 2009 ident: bib0510 article-title: Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease publication-title: J Neuroinflamm – volume: 109 start-page: 181 year: 2002 end-page: 189 ident: bib0855 article-title: Increased neopterin production and tryptophan degradation in advanced Parkinson's disease publication-title: J Neural Transm – volume: 93 start-page: 611 year: 2005 end-page: 623 ident: bib0780 article-title: Tryptophan metabolism and oxidative stress in patients with Huntington's disease publication-title: J Neurochem – volume: 35 start-page: 72 year: 2001 end-page: 79 ident: bib0840 article-title: Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro publication-title: Glia – volume: 802 start-page: 111 year: 1998 end-page: 118 ident: bib0720 article-title: Systemic publication-title: Brain Res – volume: 101 start-page: 3498 year: 2004 end-page: 3503 ident: bib0750 article-title: Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset publication-title: Proc Natl Acad Sci U S A – volume: 1304 start-page: 357 year: 2007 end-page: 361 ident: bib0845 article-title: Up-regulation of the brain indoleamine 2,3-dioxygenase activity in a mouse model of Alzheimer's disease by systemic endotoxin challenge publication-title: Int Cong Ser – volume: 60 start-page: 212 year: 1993 end-page: 218 ident: bib0725 article-title: On the production and disposition of quinolinic acid in rat brain and liver slices publication-title: J Neurochem – volume: 336 start-page: 207 year: 1985 end-page: 214 ident: bib0470 article-title: Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum publication-title: Brain Res – volume: 247 start-page: 184 year: 1982 end-page: 187 ident: bib0625 article-title: An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid publication-title: Brain Res – volume: 22 start-page: 257 year: 2010 end-page: 266 ident: bib0925 article-title: Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2,3-dioxygenase activity in vitro publication-title: J Alzheimers Dis – volume: 263 start-page: 2041 year: 1988 end-page: 2048 ident: bib0665 article-title: Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity publication-title: J Biol Chem – volume: 115 start-page: 1249 year: 1992 end-page: 1273 ident: bib0765 article-title: Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease publication-title: Brain – volume: 31 start-page: 395 year: 2005 end-page: 404 ident: bib0825 article-title: Indoleamine 2,3-dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus publication-title: Neuropathol Appl Neurobiol – volume: 159 start-page: 51 year: 1993 end-page: 54 ident: bib0525 article-title: MK-801 an N-methyl- publication-title: Neurosci Lett – volume: 47 start-page: 23 year: 1986 end-page: 30 ident: bib0735 article-title: Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro publication-title: J Neurochem – volume: 10 start-page: 83 year: 2011 end-page: 98 ident: bib0745 article-title: Huntington's disease: from molecular pathogenesis to clinical treatment publication-title: Lancet Neurol – volume: 23 start-page: 1645 year: 2013 end-page: 1655 ident: bib0680 article-title: Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine publication-title: Eur Neuropsychopharmacol – volume: 288 start-page: 36554 year: 2013 end-page: 36566 ident: bib0910 article-title: Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain publication-title: J Biol Chem – volume: 21 start-page: 7463 year: 2001 end-page: 7473 ident: bib0620 article-title: The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications publication-title: J Neurosci – volume: 11 start-page: 3857 year: 1999 end-page: 3863 ident: bib0585 article-title: 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum publication-title: Eur J Neurosci – volume: 69 start-page: 290 year: 1997 end-page: 298 ident: bib0715 article-title: Brain-specific modulation of kynurenic acid synthesis in the rat publication-title: J Neurochem – volume: 17 start-page: 455 year: 2004 end-page: 461 ident: bib0755 article-title: Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease publication-title: Neurobiol Dis – volume: 19 start-page: 609 year: 2010 end-page: 622 ident: bib0775 article-title: Expression analysis of novel striatal-enriched genes in Huntington disease publication-title: Hum Mol Genet – volume: 116 start-page: 1425 year: 1993 end-page: 1450 ident: bib0730 article-title: A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from publication-title: Brain – volume: 130 start-page: 1759 year: 2007 end-page: 1766 ident: bib0805 article-title: Microglial activation in presymptomatic Huntington's disease gene carriers publication-title: Brain – volume: 40 start-page: 4378 year: 1997 end-page: 4385 ident: bib0885 article-title: Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase publication-title: J Med Chem – volume: 145 start-page: 863 year: 2011 end-page: 874 ident: bib0875 article-title: Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration publication-title: Cell – volume: 109 start-page: 14912 year: 2012 end-page: 14917 ident: bib0920 article-title: Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation publication-title: Proc Natl Acad Sci U S A – volume: 130 start-page: 39 year: 1995 end-page: 47 ident: bib0760 article-title: Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases publication-title: J Neurol Sci – volume: 37 start-page: 939 year: 2012 end-page: 949 ident: bib0670 article-title: Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis publication-title: Neuropsychopharmacology – volume: 5 start-page: 223 year: 1980 end-page: 239 ident: bib0700 article-title: -Kynurenine: its synthesis and possible regulatory function in brain publication-title: Neurochem Res – volume: 72 start-page: 411 year: 1981 end-page: 412 ident: bib0480 article-title: Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS publication-title: Eur J Pharmacol – volume: 73 start-page: 185 year: 1996 end-page: 200 ident: bib0555 article-title: Antioxidant treatment protects striatal neurons against excitotoxic insults publication-title: Neuroscience – volume: 496 start-page: 382 year: 2013 end-page: 385 ident: bib0915 article-title: Structural basis of kynurenine 3-monooxygenase inhibition publication-title: Nature – volume: 97 start-page: 271 year: 1989 end-page: 275 ident: bib0500 article-title: Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system publication-title: Neurosci Lett – volume: 58 start-page: 1159 year: 2015 end-page: 1183 ident: bib0905 article-title: Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease publication-title: J Med Chem – volume: 42 start-page: 37 year: 1978 end-page: 43 ident: bib0485 article-title: Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice publication-title: J Neural Transm – volume: 78 start-page: 842 year: 2001 end-page: 853 ident: bib0710 article-title: Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection publication-title: J Neurochem – volume: 29 start-page: 1434 year: 2014 end-page: 1445 ident: bib0900 article-title: Targets for future clinical trials in Huntington's disease: what's in the pipeline? publication-title: Mov Disord – volume: 274 start-page: 827 year: 2007 end-page: 840 ident: bib0475 article-title: Tissue expression and biochemical characterization of human 2-amino 3-carboxymuconate 6-semialdehyde decarboxylase, a key enzyme in tryptophan catabolism publication-title: FEBS J – volume: 40 start-page: 2297 year: 2012 end-page: 2306 ident: bib0895 article-title: Metabolism and pharmacokinetics of JM6 in mice: JM6 is not a prodrug for Ro-61-8048 publication-title: Drug Metab Dispos – volume: 527 start-page: 105 year: 2003 end-page: 112 ident: bib0690 article-title: Expression of the kynurenine pathway enzymes in human microglia and macrophages publication-title: Adv Exp Med Biol – volume: 23 start-page: 1297 year: 1998 end-page: 1302 ident: bib0545 article-title: Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity publication-title: Neurochem Res – volume: 20 start-page: 1098 year: 2009 end-page: 1103 ident: bib0800 article-title: Distinct neuroinflammatory profile in post-mortem human Huntington's disease publication-title: Neuroreport – volume: 5 start-page: 1 year: 2012 end-page: 8 ident: bib0515 article-title: Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms publication-title: Int J Tryptophan Res – volume: 113 start-page: 1416 year: 2010 end-page: 1425 ident: bib0790 article-title: Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington's disease publication-title: J Neurochem – volume: 441 start-page: 29 year: 2008 end-page: 34 ident: bib0675 article-title: Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma? publication-title: Neurosci Lett – volume: 93 start-page: 12553 year: 1996 end-page: 12558 ident: bib0570 article-title: Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine publication-title: Proc Natl Acad Sci U S A – volume: 128 start-page: 1754 year: 1999 end-page: 1760 ident: bib0550 article-title: Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl publication-title: Br J Pharmacol – volume: 377 start-page: 195 year: 2000 end-page: 203 ident: bib0640 article-title: Heme: a regulator of rat hepatic tryptophan 2,3-dioxygenase? publication-title: Arch Biochem Biophys – volume: 42 start-page: 1702 year: 1992 end-page: 1706 ident: bib0860 article-title: Kynurenine pathway abnormalities in Parkinson's disease publication-title: Neurology – volume: 251 start-page: 893 year: 1988 end-page: 899 ident: bib0595 article-title: Superoxide dismutase enhances the formation of hydroxyl radicals in the reaction of 3-hydroxyanthranilic acid with molecular oxygen publication-title: Biochem J – volume: 205 start-page: 1869 year: 2008 end-page: 1877 ident: bib0795 article-title: A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease publication-title: J Exp Med – volume: 20 start-page: 792 year: 2005 ident: 10.1016/j.semcdb.2015.03.002_bib0890 article-title: Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys publication-title: Mov Disord doi: 10.1002/mds.20596 – volume: 34 start-page: 445 year: 2001 ident: 10.1016/j.semcdb.2015.03.002_bib0535 article-title: Quinolinic acid–iron(ii) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction publication-title: Free Radic Res doi: 10.1080/10715760100300391 – volume: 93 start-page: 611 year: 2005 ident: 10.1016/j.semcdb.2015.03.002_bib0780 article-title: Tryptophan metabolism and oxidative stress in patients with Huntington's disease publication-title: J Neurochem doi: 10.1111/j.1471-4159.2005.03070.x – volume: 130 start-page: 39 year: 1995 ident: 10.1016/j.semcdb.2015.03.002_bib0760 article-title: Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases publication-title: J Neurol Sci doi: 10.1016/0022-510X(94)00280-2 – volume: 21 start-page: 961 year: 2011 ident: 10.1016/j.semcdb.2015.03.002_bib0870 article-title: The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease publication-title: Curr Biol doi: 10.1016/j.cub.2011.04.028 – volume: 14 start-page: 2311 year: 2003 ident: 10.1016/j.semcdb.2015.03.002_bib0830 article-title: A beta 1–42 induces production of quinolinic acid by human macrophages and microglia publication-title: Neuroreport doi: 10.1097/00001756-200312190-00005 – volume: 5 start-page: 223 year: 1980 ident: 10.1016/j.semcdb.2015.03.002_bib0700 article-title: l-Kynurenine: its synthesis and possible regulatory function in brain publication-title: Neurochem Res doi: 10.1007/BF00964611 – volume: 496 start-page: 382 year: 2013 ident: 10.1016/j.semcdb.2015.03.002_bib0915 article-title: Structural basis of kynurenine 3-monooxygenase inhibition publication-title: Nature doi: 10.1038/nature12039 – volume: 300 start-page: 719 year: 2003 ident: 10.1016/j.semcdb.2015.03.002_bib0565 article-title: Electrochemical and in vitro evaluation of the redox-properties of kynurenine species publication-title: Biochem Biophys Res Commun doi: 10.1016/S0006-291X(02)02917-0 – volume: 40 start-page: 2297 year: 2012 ident: 10.1016/j.semcdb.2015.03.002_bib0895 article-title: Metabolism and pharmacokinetics of JM6 in mice: JM6 is not a prodrug for Ro-61-8048 publication-title: Drug Metab Dispos doi: 10.1124/dmd.112.046532 – volume: 30 start-page: 233 year: 1997 ident: 10.1016/j.semcdb.2015.03.002_bib0530 article-title: The effect of quinolinate on rat brain lipid peroxidation is dependent on iron publication-title: Neurochem Int doi: 10.1016/S0197-0186(97)90002-4 – volume: 97 start-page: 271 year: 1989 ident: 10.1016/j.semcdb.2015.03.002_bib0500 article-title: Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system publication-title: Neurosci Lett doi: 10.1016/0304-3940(89)90609-5 – volume: 40 start-page: 4378 year: 1997 ident: 10.1016/j.semcdb.2015.03.002_bib0885 article-title: Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase publication-title: J Med Chem doi: 10.1021/jm970467t – volume: 70 start-page: 299 year: 1998 ident: 10.1016/j.semcdb.2015.03.002_bib0575 article-title: 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity publication-title: J Neurochem doi: 10.1046/j.1471-4159.1998.70010299.x – volume: 93 start-page: 12553 year: 1996 ident: 10.1016/j.semcdb.2015.03.002_bib0570 article-title: Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.93.22.12553 – volume: 8 start-page: 12 year: 2014 ident: 10.1016/j.semcdb.2015.03.002_bib0660 article-title: Kynurenines in CNS disease: regulation by inflammatory cytokines publication-title: Front Neurosci doi: 10.3389/fnins.2014.00012 – volume: 112 start-page: 112 year: 2010 ident: 10.1016/j.semcdb.2015.03.002_bib0785 article-title: Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease publication-title: J Neurochem doi: 10.1111/j.1471-4159.2009.06442.x – volume: 23 start-page: 1297 year: 1998 ident: 10.1016/j.semcdb.2015.03.002_bib0545 article-title: Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity publication-title: Neurochem Res doi: 10.1023/A:1020700401678 – volume: 251 start-page: 893 year: 1988 ident: 10.1016/j.semcdb.2015.03.002_bib0595 article-title: Superoxide dismutase enhances the formation of hydroxyl radicals in the reaction of 3-hydroxyanthranilic acid with molecular oxygen publication-title: Biochem J doi: 10.1042/bj2510893 – volume: 130 start-page: 1759 year: 2007 ident: 10.1016/j.semcdb.2015.03.002_bib0805 article-title: Microglial activation in presymptomatic Huntington's disease gene carriers publication-title: Brain doi: 10.1093/brain/awm044 – volume: 247 start-page: 184 year: 1982 ident: 10.1016/j.semcdb.2015.03.002_bib0625 article-title: An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid publication-title: Brain Res doi: 10.1016/0006-8993(82)91048-4 – volume: 263 start-page: 2041 year: 1988 ident: 10.1016/j.semcdb.2015.03.002_bib0665 article-title: Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)77982-4 – volume: 16 start-page: 77 year: 2009 ident: 10.1016/j.semcdb.2015.03.002_bib0540 article-title: Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons publication-title: Neurotox Res doi: 10.1007/s12640-009-9051-z – volume: 23 start-page: 1645 year: 2013 ident: 10.1016/j.semcdb.2015.03.002_bib0680 article-title: Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2013.03.008 – volume: 32 start-page: 11 year: 2000 ident: 10.1016/j.semcdb.2015.03.002_bib0560 article-title: Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions publication-title: Free Radic Res doi: 10.1080/10715760000300021 – volume: 42 start-page: 37 year: 1978 ident: 10.1016/j.semcdb.2015.03.002_bib0485 article-title: Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice publication-title: J Neural Transm doi: 10.1007/BF01262727 – volume: 40 start-page: 621 year: 2002 ident: 10.1016/j.semcdb.2015.03.002_bib0505 article-title: Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes publication-title: Neurochem Int doi: 10.1016/S0197-0186(01)00133-4 – volume: 283 start-page: 7390 year: 2008 ident: 10.1016/j.semcdb.2015.03.002_bib0685 article-title: Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment publication-title: J Biol Chem doi: 10.1074/jbc.M708192200 – volume: 336 start-page: 207 year: 1985 ident: 10.1016/j.semcdb.2015.03.002_bib0470 article-title: Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum publication-title: Brain Res doi: 10.1016/0006-8993(85)90647-X – volume: 16 start-page: 1139 year: 1991 ident: 10.1016/j.semcdb.2015.03.002_bib0520 article-title: Quinolinic acid is a potent lipid peroxidant in rat brain homogenates publication-title: Neurochem Res doi: 10.1007/BF00966592 – volume: 6 issue: 36 year: 2009 ident: 10.1016/j.semcdb.2015.03.002_bib0510 article-title: Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease publication-title: J Neuroinflamm – volume: 39 start-page: 7266 year: 2000 ident: 10.1016/j.semcdb.2015.03.002_bib0590 article-title: 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction publication-title: Biochemistry doi: 10.1021/bi992997s – volume: 64 start-page: 74 year: 2007 ident: 10.1016/j.semcdb.2015.03.002_bib0645 article-title: Biochemical mechanisms leading to tryptophan 2,3-dioxygenase activation publication-title: Arch Insect Biochem Physiol doi: 10.1002/arch.20159 – volume: 37 start-page: 939 year: 2012 ident: 10.1016/j.semcdb.2015.03.002_bib0670 article-title: Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.277 – volume: 441 start-page: 29 year: 2008 ident: 10.1016/j.semcdb.2015.03.002_bib0675 article-title: Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma? publication-title: Neurosci Lett doi: 10.1016/j.neulet.2008.06.007 – volume: 263 start-page: 345 year: 2013 ident: 10.1016/j.semcdb.2015.03.002_bib0820 article-title: Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/s00406-012-0384-x – volume: 58 start-page: 1159 year: 2015 ident: 10.1016/j.semcdb.2015.03.002_bib0905 article-title: Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease publication-title: J Med Chem doi: 10.1021/jm501350y – volume: 145 start-page: 863 year: 2011 ident: 10.1016/j.semcdb.2015.03.002_bib0875 article-title: Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration publication-title: Cell doi: 10.1016/j.cell.2011.05.020 – volume: 60 start-page: 212 year: 1993 ident: 10.1016/j.semcdb.2015.03.002_bib0725 article-title: On the production and disposition of quinolinic acid in rat brain and liver slices publication-title: J Neurochem doi: 10.1111/j.1471-4159.1993.tb05840.x – volume: 56 start-page: 2007 year: 1991 ident: 10.1016/j.semcdb.2015.03.002_bib0740 article-title: Blood–brain barrier transport of kynurenines: implications for brain synthesis and metabolism publication-title: J Neurochem doi: 10.1111/j.1471-4159.1991.tb03460.x – volume: 42 start-page: 1702 year: 1992 ident: 10.1016/j.semcdb.2015.03.002_bib0860 article-title: Kynurenine pathway abnormalities in Parkinson's disease publication-title: Neurology doi: 10.1212/WNL.42.9.1702 – volume: 73 start-page: 185 year: 1996 ident: 10.1016/j.semcdb.2015.03.002_bib0555 article-title: Antioxidant treatment protects striatal neurons against excitotoxic insults publication-title: Neuroscience doi: 10.1016/0306-4522(96)00034-6 – volume: 802 start-page: 111 year: 1998 ident: 10.1016/j.semcdb.2015.03.002_bib0720 article-title: Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain publication-title: Brain Res doi: 10.1016/S0006-8993(98)00577-0 – volume: 47 start-page: 23 year: 1986 ident: 10.1016/j.semcdb.2015.03.002_bib0735 article-title: Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro publication-title: J Neurochem doi: 10.1111/j.1471-4159.1986.tb02826.x – volume: 23 start-page: 190 year: 2006 ident: 10.1016/j.semcdb.2015.03.002_bib0770 article-title: Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2006.02.011 – volume: 69 start-page: 290 year: 1997 ident: 10.1016/j.semcdb.2015.03.002_bib0715 article-title: Brain-specific modulation of kynurenic acid synthesis in the rat publication-title: J Neurochem doi: 10.1046/j.1471-4159.1997.69010290.x – volume: 19 start-page: 609 year: 2010 ident: 10.1016/j.semcdb.2015.03.002_bib0775 article-title: Expression analysis of novel striatal-enriched genes in Huntington disease publication-title: Hum Mol Genet doi: 10.1093/hmg/ddp527 – volume: 377 start-page: 195 year: 2000 ident: 10.1016/j.semcdb.2015.03.002_bib0640 article-title: Heme: a regulator of rat hepatic tryptophan 2,3-dioxygenase? publication-title: Arch Biochem Biophys doi: 10.1006/abbi.2000.1755 – volume: 5 start-page: 1 year: 2012 ident: 10.1016/j.semcdb.2015.03.002_bib0515 article-title: Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms publication-title: Int J Tryptophan Res – volume: 33 start-page: 538 year: 2011 ident: 10.1016/j.semcdb.2015.03.002_bib0615 article-title: On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress publication-title: Neurotoxicol Teratol doi: 10.1016/j.ntt.2011.07.002 – volume: 109 start-page: 14912 year: 2012 ident: 10.1016/j.semcdb.2015.03.002_bib0920 article-title: Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1203083109 – volume: 22 start-page: 257 year: 2010 ident: 10.1016/j.semcdb.2015.03.002_bib0925 article-title: Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2,3-dioxygenase activity in vitro publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-100684 – volume: 11 start-page: 3857 year: 1999 ident: 10.1016/j.semcdb.2015.03.002_bib0585 article-title: 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum publication-title: Eur J Neurosci doi: 10.1046/j.1460-9568.1999.00806.x – volume: 54 start-page: 156 year: 1990 ident: 10.1016/j.semcdb.2015.03.002_bib0705 article-title: Uptake of kynurenine into rat brain slices publication-title: J Neurochem doi: 10.1111/j.1471-4159.1990.tb13296.x – volume: 78 start-page: 842 year: 2001 ident: 10.1016/j.semcdb.2015.03.002_bib0710 article-title: Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection publication-title: J Neurochem doi: 10.1046/j.1471-4159.2001.00498.x – volume: 116 start-page: 1425 issue: Pt 6 year: 1993 ident: 10.1016/j.semcdb.2015.03.002_bib0730 article-title: A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from l-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate publication-title: Brain doi: 10.1093/brain/116.6.1425 – volume: 37 start-page: 526 year: 2005 ident: 10.1016/j.semcdb.2015.03.002_bib0865 article-title: A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease publication-title: Nat Genet doi: 10.1038/ng1542 – volume: 274 start-page: 827 year: 2007 ident: 10.1016/j.semcdb.2015.03.002_bib0475 article-title: Tissue expression and biochemical characterization of human 2-amino 3-carboxymuconate 6-semialdehyde decarboxylase, a key enzyme in tryptophan catabolism publication-title: FEBS J doi: 10.1111/j.1742-4658.2007.05635.x – volume: 72 start-page: 411 year: 1981 ident: 10.1016/j.semcdb.2015.03.002_bib0480 article-title: Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(81)90587-2 – volume: 205 start-page: 1869 year: 2008 ident: 10.1016/j.semcdb.2015.03.002_bib0795 article-title: A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease publication-title: J Exp Med doi: 10.1084/jem.20080178 – volume: 37 start-page: 408 year: 2009 ident: 10.1016/j.semcdb.2015.03.002_bib0630 article-title: Oxidation of l-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase publication-title: Biochem Soc Trans doi: 10.1042/BST0370408 – volume: 17 start-page: 455 year: 2004 ident: 10.1016/j.semcdb.2015.03.002_bib0755 article-title: Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2004.07.006 – volume: 22 start-page: 1331 year: 1983 ident: 10.1016/j.semcdb.2015.03.002_bib0495 article-title: On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds publication-title: Neuropharmacology doi: 10.1016/0028-3908(83)90221-6 – volume: 21 start-page: 7463 year: 2001 ident: 10.1016/j.semcdb.2015.03.002_bib0620 article-title: The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications publication-title: J Neurosci doi: 10.1523/JNEUROSCI.21-19-07463.2001 – volume: 288 start-page: 36554 year: 2013 ident: 10.1016/j.semcdb.2015.03.002_bib0910 article-title: Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain publication-title: J Biol Chem doi: 10.1074/jbc.M113.503813 – volume: 87 start-page: 2506 year: 1990 ident: 10.1016/j.semcdb.2015.03.002_bib0600 article-title: Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.87.7.2506 – volume: 43 start-page: 291 year: 2015 ident: 10.1016/j.semcdb.2015.03.002_bib0930 article-title: The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer's disease publication-title: J Alzheimers Dis doi: 10.3233/JAD-140414 – volume: 82 start-page: 3210 year: 2014 ident: 10.1016/j.semcdb.2015.03.002_bib0635 article-title: Structural and functional analyses of human tryptophan 2,3-dioxygenase publication-title: Proteins doi: 10.1002/prot.24653 – volume: 249 start-page: 144 year: 2013 ident: 10.1016/j.semcdb.2015.03.002_bib1930 article-title: The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain publication-title: Exp Neurol doi: 10.1016/j.expneurol.2013.08.007 – volume: 15 start-page: 303 year: 2009 ident: 10.1016/j.semcdb.2015.03.002_bib0580 article-title: 5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurones publication-title: Neurotox Res doi: 10.1007/s12640-009-9034-0 – volume: 128 start-page: 1754 year: 1999 ident: 10.1016/j.semcdb.2015.03.002_bib0550 article-title: Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0702940 – volume: 31 start-page: 395 year: 2005 ident: 10.1016/j.semcdb.2015.03.002_bib0825 article-title: Indoleamine 2,3-dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus publication-title: Neuropathol Appl Neurobiol doi: 10.1111/j.1365-2990.2005.00655.x – volume: 109 start-page: 181 year: 2002 ident: 10.1016/j.semcdb.2015.03.002_bib0855 article-title: Increased neopterin production and tryptophan degradation in advanced Parkinson's disease publication-title: J Neural Transm doi: 10.1007/s007020200014 – volume: 115 start-page: 1249 issue: Pt 5 year: 1992 ident: 10.1016/j.semcdb.2015.03.002_bib0765 article-title: Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease publication-title: Brain doi: 10.1093/brain/115.5.1249 – volume: 527 start-page: 105 year: 2003 ident: 10.1016/j.semcdb.2015.03.002_bib0690 article-title: Expression of the kynurenine pathway enzymes in human microglia and macrophages publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4615-0135-0_12 – volume: 10 start-page: 83 year: 2011 ident: 10.1016/j.semcdb.2015.03.002_bib0745 article-title: Huntington's disease: from molecular pathogenesis to clinical treatment publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70245-3 – volume: 91 start-page: 705 year: 2013 ident: 10.1016/j.semcdb.2015.03.002_bib0880 article-title: The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease publication-title: J Mol Med (Berl.) doi: 10.1007/s00109-013-1046-9 – volume: 101 start-page: 3498 year: 2004 ident: 10.1016/j.semcdb.2015.03.002_bib0750 article-title: Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0308679101 – volume: 55 start-page: 204 year: 2010 ident: 10.1016/j.semcdb.2015.03.002_bib0810 article-title: Kynurenine and its metabolites in Alzheimer's disease patients publication-title: Adv Med Sci doi: 10.2478/v10039-010-0023-6 – volume: 38 start-page: 1609 year: 2013 ident: 10.1016/j.semcdb.2015.03.002_bib0650 article-title: NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice publication-title: Neuropsychopharmacology doi: 10.1038/npp.2013.71 – volume: 219 start-page: 316 year: 1983 ident: 10.1016/j.semcdb.2015.03.002_bib0490 article-title: Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain publication-title: Science doi: 10.1126/science.6849138 – volume: 1304 start-page: 357 year: 2007 ident: 10.1016/j.semcdb.2015.03.002_bib0845 article-title: Up-regulation of the brain indoleamine 2,3-dioxygenase activity in a mouse model of Alzheimer's disease by systemic endotoxin challenge publication-title: Int Cong Ser doi: 10.1016/j.ics.2007.07.026 – volume: 1589 start-page: 1 year: 2014 ident: 10.1016/j.semcdb.2015.03.002_bib0610 article-title: The Janus faces of 3-hydroxykynurenine: dual redox modulatory activity and lack of neurotoxicity in the rat striatum publication-title: Brain Res doi: 10.1016/j.brainres.2014.09.034 – volume: 4 start-page: e6344 year: 2009 ident: 10.1016/j.semcdb.2015.03.002_bib0850 article-title: The excitotoxin quinolinic acid induces tau phosphorylation in human neurons publication-title: PLoS ONE doi: 10.1371/journal.pone.0006344 – volume: 113 start-page: 1416 year: 2010 ident: 10.1016/j.semcdb.2015.03.002_bib0790 article-title: Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington's disease publication-title: J Neurochem doi: 10.1111/j.1471-4159.2010.06675.x – volume: 15 start-page: 161 year: 2010 ident: 10.1016/j.semcdb.2015.03.002_bib0815 article-title: Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease publication-title: Redox Rep doi: 10.1179/174329210X12650506623645 – volume: 20 start-page: 1098 year: 2009 ident: 10.1016/j.semcdb.2015.03.002_bib0800 article-title: Distinct neuroinflammatory profile in post-mortem human Huntington's disease publication-title: Neuroreport doi: 10.1097/WNR.0b013e32832e34ee – volume: 35 start-page: 72 year: 2001 ident: 10.1016/j.semcdb.2015.03.002_bib0840 article-title: Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro publication-title: Glia doi: 10.1002/glia.1072 – volume: 50 start-page: 83 year: 2007 ident: 10.1016/j.semcdb.2015.03.002_bib0605 article-title: In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain publication-title: Neurochem Int doi: 10.1016/j.neuint.2006.04.017 – volume: 271 start-page: 19140 year: 1996 ident: 10.1016/j.semcdb.2015.03.002_bib0655 article-title: Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene publication-title: J Biol Chem doi: 10.1074/jbc.271.32.19140 – volume: 29 start-page: 1434 year: 2014 ident: 10.1016/j.semcdb.2015.03.002_bib0900 article-title: Targets for future clinical trials in Huntington's disease: what's in the pipeline? publication-title: Mov Disord doi: 10.1002/mds.26007 – volume: 159 start-page: 51 year: 1993 ident: 10.1016/j.semcdb.2015.03.002_bib0525 article-title: MK-801 an N-methyl-d-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum publication-title: Neurosci Lett doi: 10.1016/0304-3940(93)90796-N – volume: 28 start-page: 615 year: 2000 ident: 10.1016/j.semcdb.2015.03.002_bib0695 article-title: Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway publication-title: Free Radic Biol Med doi: 10.1016/S0891-5849(99)00272-5 – volume: 110 start-page: 791 year: 2009 ident: 10.1016/j.semcdb.2015.03.002_bib0835 article-title: Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1–42: implications for the pathogenesis of Alzheimer's disease publication-title: J Neurochem doi: 10.1111/j.1471-4159.2009.06175.x |
| SSID | ssj0004926 |
| Score | 2.5595164 |
| SecondaryResourceType | review_article |
| Snippet | Neuroactive metabolites of the kynurenine pathway (KP) of tryptophan degradation have been closely linked to the pathogenesis of several neurodegenerative... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 134 |
| SubjectTerms | Alzheimer's disease Animals Humans Huntington's disease KMO Kynurenine - metabolism Kynurenine 3-monooxygenase Kynurenine pathway Metabolic Networks and Pathways Neurodegeneration Neurodegenerative Diseases - metabolism Parkinson's disease Tryptophan - metabolism |
| Title | The kynurenine pathway and neurodegenerative disease |
| URI | https://dx.doi.org/10.1016/j.semcdb.2015.03.002 https://www.ncbi.nlm.nih.gov/pubmed/25773161 https://www.proquest.com/docview/1695987971 |
| Volume | 40 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFA5DEXwR784bFXytW3Np2scxHPM2RB3sLeRWmZduuA3Zi7_dnKad-DAEn0pK0obvJCcH8p3vIHSuicVKKR7qjLGQxlKHKnMGodJo6pyh0QaSk-96cbdPrwdsUEPtKhcGaJWl7_c-vfDW5ZtGiWZjPBw2HqNm4qJ7DCFNIQwOGeyUw1q_-PqheYAgnifZ0xB6V-lzBcdrYt-1UUDwYl7qFC87npaFn8Ux1NlEG2X8GLT8FLdQzebbaM1XlJzvIOrMHrzOIfs3d_FjAAWHP-U8kLkJCulKY58LoWnwckF5O7OL-p3Lp3Y3LAsjhJpROnURMYfrLcpklikqWUqMgqLmiY1i3ORYQtEWmpCMxLBFs5hzY0AYJqEWM2zJHlrJR7k9QIGWiimb8ThmkuJMy9RGqcWaE_dNi9M6IhUeQpeq4VC84k1U9LAX4VEUgKJoEuFQrKNwMWrsVTP-6M8rqMUv6wvn2P8YeVZZRriNAbcdMrej2UQ4gFia8JRHdbTvTbaYi_NTULErOvz3f4_QOrQ8h-cYrUw_ZvbEhSdTdVqsv1O02mo_3N7D8-qm2_sGVIXkiA |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB1BEYILYqesQeIa2jh2nBxRBSpLuQBSb5a3oLIERFuhXvh2PHFSxKFC4prYiTVjj580M-8BnOjYEqUUD3XOWEgTqUOVO4dQaTR1wdBog83Jvduk-0Cv-qw_B526FwbLKqvY72N6Ga2rJ63Kmq33waB1F7VTh-4JQpqSGHweFijKHLhNffr1U-eBjHi-yp6GOLzunyuLvIb2VRuFFV7Mc52SWffTLPxZ3kMXq7BSAcjgzK9xDeZssQ6LXlJysgHU-T14nmD7b-EAZICKw59yEsjCBCV3pbGPJdM0hrmgSs9swsPF-X2nG1bKCKFmlI4cJOaY36JM5rmikmWxUahqntooIW1OJKq20DTO4wTPaJ5wbgwyw6TUEkZsvAWN4q2wOxBoqZiyOU8SJinJtcxslFmieey-aUnWhLi2h9AVbTiqV7yIuj7sSXgrCrSiaMfCWbEJ4XTWu6fN-GM8r00tfrlfuMj-x8zj2jPCnQxMd8jCvo2HwhmIZSnPeNSEbe-y6VpcoELJrmj33_89gqXufe9G3FzeXu_BMr7xBT370Bh9jO2BwyojdVjuxW9xd-R8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+kynurenine+pathway+and+neurodegenerative+disease&rft.jtitle=Seminars+in+cell+%26+developmental+biology&rft.au=Maddison%2C+Daniel+C.&rft.au=Giorgini%2C+Flaviano&rft.date=2015-04-01&rft.issn=1084-9521&rft.volume=40&rft.spage=134&rft.epage=141&rft_id=info:doi/10.1016%2Fj.semcdb.2015.03.002&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_semcdb_2015_03_002 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1084-9521&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1084-9521&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1084-9521&client=summon |